Antibiotics, FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to congressional requesters.
| Author/creator | United States |
| Format | Electronic |
| Publication | [Washington, D.C.] : United States Government Accountability Office, 2017. |
| Description | 1 online resource (ii, 31 pages) |
| Supplemental Content | https://purl.fdlp.gov/GPO/gpo78114 |
| Subjects |
| Portion of title | FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance |
| Variant title | Antibiotics, Food and Drug Administration has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance |
| Running title | GAO-17-189 FDA qualified infectious disease products |
| General note | "January 2017." |
| General note | "GAO-17-189." |
| General note | CRDP Program record. |
| Bibliography note | Includes bibliographical references. |
| Source of description | Description based on online resource, PDF version; title from cover (GAO web site, viewed Mar. 6, 2017). |
| Technical rpt number | GAO-17-189 |
| GPO item number | 0546-D (online) |
| Govt. docs number | GA 1.13:GAO-17-189 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |